FDA Inspection 752377 — Takeda Pharmaceutical Company Limited
The FDA completed an inspection of Takeda Pharmaceutical Company Limited on November 3, 2011 in Fayetteville, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 3, 2011
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fayetteville, AR (United States)